US 10526397
Non-immunogenic single domain antibodies
granted A61PA61P29/00A61P37/06
Quick answer
US patent 10526397 (Non-immunogenic single domain antibodies) held by Inhibrx, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P29/00, A61P37/06